|
🐜
|
ERG Transcription Factor as an Immunohistochemical Marker for Vascular Endothelial Tumors and Prostatic Carcinoma
7 auth.
M. Miettinen,
Zengfeng Wang,
A. Paetau,
Shyh-Han Tan,
A. Dobi,
S. Srivastava,
...
I. Sesterhenn
|
8 |
2011 |
8
🐜
|
|
🐜
|
TMPRSS2-ERG fusion, a common genomic alteration in prostate cancer activates C-MYC and abrogates prostate epithelial differentiation
25 auth.
Chen Sun,
A. Dobi,
A. Mohamed,
Hongzhen Li,
Rajesh L. Thangapazham,
B. Furusato,
B. Furusato,
S. Shaheduzzaman,
Shyh-Han Tan,
Ganesan Vaidyanathan,
Eric J. Whitman,
Eric J. Whitman,
D. Hawksworth,
D. Hawksworth,
Yongmei Chen,
...
M. Nau,
V. Patel,
M. Vahey,
J. Gutkind,
T. Sreenath,
G. Petrovics,
I. Sesterhenn,
D. Mcleod,
David G. Mcleod,
S. Srivastava
|
8 |
2008 |
8
🐜
|
|
🐜
|
Frequent overexpression of ETS-related gene-1 (ERG1) in prostate cancer transcriptome
16 auth.
G. Petrovics,
Aijun Liu,
S. Shaheduzzaman,
B. Furusato,
Chen Sun,
Yongmei Chen,
M. Nau,
L. Ravindranath,
Yidong Chen,
A. Dobi,
...
V. Srikantan,
I. Sesterhenn,
D. Mcleod,
M. Vahey,
J. Moul,
S. Srivastava
|
7 |
2006 |
7
🐜
|
|
🐜
|
ERG oncoprotein expression in prostate cancer: clonal progression of ERG-positive tumor cells and potential for ERG-based stratification
16 auth.
B. Furusato,
B. Furusato,
Shyh-Han Tan,
D. Young,
A. Dobi,
Chen Sun,
A. Mohamed,
Rajesh L. Thangapazham,
Yongmei Chen,
Gary McMaster,
...
T. Sreenath,
G. Petrovics,
D. Mcleod,
D. Mcleod,
S. Srivastava,
I. Sesterhenn
|
7 |
2010 |
7
🐜
|
|
🐜
|
Frequent overexpression of ETS-related gene-1 (ERG1) in prostate cancer transcriptome
16 auth.
G. Petrovics,
Aijun Liu,
S. Shaheduzzaman,
Bungo Furasato,
Chen Sun,
Yongmei Chen,
M. Nau,
L. Ravindranath,
Yidong Chen,
A. Dobi,
...
V. Srikantan,
I. Sesterhenn,
D. Mcleod,
M. Vahey,
J. Moul,
S. Srivastava
|
7 |
2005 |
7
🐜
|
|
🐜
|
Implementation of Germline Testing for Prostate Cancer: Philadelphia Prostate Cancer Consensus Conference 2019.
92 auth.
V. Giri,
K. Knudsen,
W. Kelly,
Heather H. Cheng,
K. Cooney,
Michael Cookson,
W. Dahut,
S. Weissman,
H. Soule,
D. Petrylak,
A. Dicker,
S. AlDubayan,
A. Toland,
C. Pritchard,
C. Pettaway,
...
M. Daly,
J. Mohler,
J. Parsons,
P. Carroll,
R. Pilarski,
Amie M. Blanco,
A. Woodson,
A. Rahm,
M. Taplin,
T. Polascik,
B. Helfand,
Colette Hyatt,
A. Morgans,
F. Feng,
M. Mullane,
J. Powers,
R. Concepcion,
D. Lin,
R. Wender,
J. Mark,
A. Costello,
A. Burnett,
O. Sartor,
W. Isaacs,
Jianfeng Xu,
J. Weitzel,
G. Andriole,
H. Beltran,
A. Briganti,
Lyndsey Byrne,
Anne E. Calvaresi,
T. Chandrasekar,
David Y. T. Chen,
R. Den,
A. Dobi,
E. Crawford,
J. Eastham,
S. Eggener,
M. Freedman,
M. Garnick,
Partrick T Gomella,
N. Handley,
M. Hurwitz,
J. Izes,
R. Karnes,
C. Lallas,
L. Languino,
S. Loeb,
A. López,
K. Loughlin,
G. Lu-Yao,
S. Malkowicz,
M. Mann,
P. Mille,
M. Miner,
T. Morgan,
J. Moreno,
L. Mucci,
R. Myers,
S. Nielsen,
Brock O'Neil,
W. Pinover,
P. Pinto,
Wendy L. Poage,
G. Raj,
T. Rebbeck,
C. Ryan,
H. Sandler,
M. Schiewer,
E. M. Scott,
Brittany M. Szymaniak,
W. Tester,
E. Trabulsi,
N. Vapiwala,
E. Yu,
C. Zeigler-Johnson,
L. Gomella
|
7 |
2020 |
7
🐜
|
|
🐬
|
Prostate cancer: Diagnostic performance of the PCA3 urine test
George Leighton Lee,
A. Dobi,
S. Srivastava
|
7 |
2011 |
7
🐬
|
|
🐜
|
Mapping of TMPRSS2–ERG fusions in the context of multi-focal prostate cancer
10 auth.
B. Furusato,
Chunling Gao,
L. Ravindranath,
Yongmei Chen,
J. Cullen,
D. Mcleod,
...
A. Dobi,
S. Srivastava,
G. Petrovics,
I. Sesterhenn
|
7 |
2008 |
7
🐜
|
|
🐜
|
miR-30 as a tumor suppressor connects EGF/Src signal to ERG and EMT
10 auth.
C. Kao,
A. Martiniez,
Xubao Shi,
Jun Yang,
Christopher H. Evans,
A. Dobi,
...
R. D. White,
H. Kung,
H. Kung,
H. Kung
|
7 |
2014 |
7
🐜
|
|
🐜
|
Delineation of TMPRSS2-ERG Splice Variants in Prostate Cancer
16 auth.
Ying Hu,
A. Dobi,
T. Sreenath,
C. Cook,
Atekelt Y. Tadase,
L. Ravindranath,
J. Cullen,
B. Furusato,
Yongmei Chen,
Rajesh L. Thangapazham,
...
A. Mohamed,
Chen Sun,
I. Sesterhenn,
D. Mcleod,
G. Petrovics,
S. Srivastava
|
6 |
2008 |
6
🐜
|
|
🐢
|
Androgen receptor and prostate cancer
E. Richter,
E. Richter,
S. Srivastava,
A. Dobi
|
6 |
2007 |
6
🐢
|
